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Abstract
Purpose—Few studies have explored measures of function across a range of health outcomes in 
a general working population. Using four upper extremity (UE) case definitions from the scientific 
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literature, we described the performance of functional measures of work, activities of daily living, 
and overall health.
Methods—A sample of 573 workers completed several functional measures: modified recall 
versions of the QuickDASH, Levine Functional Status Scale (FSS), DASH Work module (DASH-
W), and standard SF-8 physical component score. We determined case status based on four UE 
case definitions: 1) UE symptoms, 2) UE musculoskeletal disorders (MSD), 3) carpal tunnel 
syndrome (CTS), and 4) work limitations due to UE symptoms. We calculated effect sizes for each 
case definition to show the magnitude of the differences that were detected between cases and 
non-cases for each case definition on each functional measure. Sensitivity and specificity analyses 
showed how well each measure identified functional impairments across the UE case definitions.
Results—All measures discriminated between cases and non-cases for each case definition with 
the largest effect sizes for CTS and work limitations, particularly for the modified FSS and DASH-
W measures. Specificity was high and sensitivity was low for outcomes of UE symptoms and UE 
MSD in all measures. Sensitivity was high for CTS and work limitations.
Conclusions—Functional measures developed specifically for use in clinical, treatment-seeking 
populations may identify mild levels of impairment in relatively healthy, active working 
populations, but measures performed better among workers with CTS or those reporting 
limitations at work.
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Introduction
Assessment of functional outcomes related to health is necessary for both researchers and 
clinicians as diagnosis alone is a poor predictor of clinical and functional outcomes [1]. 
Measurement of functional outcomes is becoming increasingly important for assessing 
improvement in health-related quality of life of patients or populations, justifying and 
obtaining reimbursement for healthcare services, providing an economic interpretation of the 
burden of chronic diseases, and demonstrating efficacy of interventions in clinical trials [2–
5]. Many measures of the impact of musculoskeletal disorders (MSDs) and chronic health 
conditions on the performance of functional activities have been developed over the last two 
decades [6–8]. Although some measures have undergone extensive psychometric testing to 
determine their reliability and validity, few studies are available to guide researchers and 
clinicians about which measure(s) are best suited for use in a given setting, population, or 
stage of disease severity [3, 9, 10].
Some measures of upper extremity function that have been used in recent musculoskeletal 
research studies, such as the Quick Disabilities of the Arm, Shoulder, and Hand 
(QuickDASH) [11], the Work module of the DASH (DASH-W), and the Functional Status 
Scale (FSS) from the Boston Carpal Tunnel Questionnaire [12], were designed and validated 
for use in clinical populations. The QuickDASH is a region-specific measure that was 
designed to assess functional outcomes relevant to a range of conditions affecting the upper 
extremity (UE) [13]. The Work module of the DASH (DASH-W) is designed to assess 
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difficulties with work performance due to UE disorders. The QuickDASH and DASH-W 
have been tested and widely used in orthopedic and rehabilitation settings among patients 
for many different UE musculoskeletal disorders (MSDs) [3, 14–18]. However, both 
workplace-based studies and comparative studies against other functional measures have 
been more limited, especially for the DASH-W [19–24]. The FSS was designed for use in 
clinical patients seeking treatment for symptoms of carpal tunnel syndrome (CTS), and has 
primarily been tested in patients undergoing surgical interventions for CTS [12, 25]. The 
Short-form 8 health survey (SF-8) is a generic health status measure that assesses multiple 
domains of health and well-being, and was developed for assessment of health-related 
quality of life in national health surveys [26]. The SF-8 has been tested in both general 
population samples and specific patient samples [26, 27].
Clinical populations are comprised of people who are treatment-seeking and likely represent 
a more symptomatic and severe range of disease than found in general or working 
populations. It is unclear how well measures designed for clinical populations perform in 
relatively healthy active working populations [19, 20] and whether the response scales are 
able to capture functional limitations corresponding to early stage disease [28]. Using 
functional measures in working populations may identify early stages of disease, allowing 
for interventions to improve work ability, prevent disability, and promote return to work 
following injury [29, 19–21]. Epidemiological studies have used a range of case definitions 
associated with MSD outcomes including symptoms alone, symptoms plus physical signs, or 
various functional outcomes [30–32]. Simultaneous comparison of the performance of 
multiple health measures against various UE MSD outcomes would inform research and 
clinical practice regarding which measure(s) may be used to identify mild levels of 
impairment in relatively healthy, active working populations.
The purpose of this study was to evaluate the performance of several standardized measures 
of functional work performance, activities of daily living, and overall health in relation to 
four upper extremity (UE) case definitions: 1) UE symptoms, 2) UE musculoskeletal 




Study participants were subjects in the prospective Predictors of Carpal Tunnel Syndrome 
(PrediCTS) study. Subjects were enrolled in the PrediCTS study (2004–2006) as full-time, 
newly hired workers in construction, service, and clerical jobs. Detailed descriptions of 
subject recruitment for the PrediCTS study may be found in several prior publications [33, 
34, 32, 35]. The present analysis included subjects who completed a follow-up visit between 
March 2012 and August 2013, consisting of a self-reported questionnaire, physical 
examination of the upper extremity, and nerve conduction studies of the hands. This study 
was approved by the Institutional Review Board of the Washington University in St. Louis 
School of Medicine. All subjects provided written informed consent and were compensated.
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Subjects completed self-reported questionnaires collecting information about demographics, 
employment history, physical and psychosocial job exposures, UE symptoms, and functional 
and work limitations related to UE symptoms. Trained research technicians performed a 
standardized physical examination for clinical signs of UE MSDs, including tenderness to 
palpation and standard provocative maneuvers. Research technicians also performed 
standardized bilateral nerve conduction testing of the median and ulnar nerves at the wrist to 
determine the presence of abnormal median neuropathy consistent with carpal tunnel 
syndrome. Specific methods are described in previous publications [36–38].
Functional Measures
As described below, standardized measures assessed three general domains of health and 
functioning: activities of daily living (ADL), work performance, and overall health. 
Assessments were administered to all participants, although the 1-year recall modified 
QuickDASH was only administered to subjects with UE symptoms.
1-year recall modified QuickDASH—The QuickDASH is an 11-item, shortened version 
of the Disabilities of the Arm, Shoulder, and Hand (DASH) outcome measure. The 
QuickDASH is designed to measure physical functioning in people with UE disorders. 
Respondents are asked to rate their ability to perform various activities of daily living and 
the severity of their symptoms, on a scale from “1” to “5.” A minimum of 10 of the 11 
QuickDASH items must be completed in order for a score to be calculated. Completed 
responses are summed and averaged. The average value is transformed to a 0 to 100 scale by 
subtracting one and multiplying by 25. Higher scores indicate greater disability [15]. The 
QuickDASH has been shown to be reliable and valid in various clinical populations [15, 39, 
40]. The recall period for the QuickDASH was modified from the original timeframe of 
“during the past week” to “when your symptoms were the worst in the past year” to parallel 
the reference time frame used for other measures in the PrediCTS study. Due to the modified 
recall period, we refer to the QuickDASH in this study as the 1-year recall modified 
QuickDASH.
Modified Functional Status Scale—The Functional Status Scale (FSS) from the Boston 
Carpal Tunnel Questionnaire is an 8-item questionnaire originally developed by Levine et al. 
[12] to assess functional abilities in patients with CTS. The FSS has shown good 
reproducibility, internal consistency and responsiveness to change in surgical patients [12]. 
Each item of the FSS is rated on a scale from “1” “no difficulty” to “5” “unable.” The 
overall score for the FSS is calculated as the mean of the completed items, and ranges from 
1 to 5 [12]. Higher scores indicate greater disability. Similar to the QuickDASH, the recall 
period for the FSS was modified from the original two-week recall period to one year, and is 
described as the modified FSS in this study.
1-year recall modified DASH Work Module—The DASH Work module (DASH-W) is 
a 4-item scale assessing the impact of UE conditions on physical work ability. Workers are 
asked to rate their difficulty in performing work activities on a scale from “1” “no difficulty” 
to “5” “unable.” All 4 items must be completed in order to calculate a score. The DASH-W 
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is scored by summing all four responses and dividing by 4 to get an average. Then, 1 is 
subtracted and the value is multiplied by 25 to get a final score ranging from 0 to 100. 
Higher scores indicate greater disability [41, 42]. We also used a one-year recall period for 
the DASH-W, in order to be consistent with the other outcome measures, which is referred 
to as the 1-year recall modified DASH-W.
Short form-8 (SF-8) Health Survey: Physical Component Score—The SF-8 
Health Survey is an 8-item scale designed to assess self-perception of overall health and 
ability to perform daily activities. The SF-8 has shown acceptable reliability compared with 
the longer, more widely tested SF-36 health survey [26]. Items are scored on “1” to “5” 
scales with various verbal anchors. The SF-8 was scored to yield the physical component 
score (PCS-8) according to the developers’ recommendations [26]. If any items were 
missing, a score was not calculated. Higher scores on the PCS-8 indicate better health. In 
contrast to the other measures in this study, the PCS-8 used a 4-week recall period.
Case definitions
Subjects were determined to meet or not meet each of the four UE case definitions described 
below for 1) UE symptoms, 2) UE MSD, 3) CTS, and 4) work limitations due to UE 
symptoms.
UE Symptoms—Subjects reported symptoms in three regions of the UE that would 
commonly be used in epidemiological case definitions for UE MSDs. “In the past YEAR, 
have you had any RECURRING (repeated) symptoms in your (Shoulders/upper arms, 
Elbow/forearms, or Hands/Wrists/fingers) more than 3 times or lasting more than ONE 
week?” [43]
UE MSD—Among subjects reporting UE symptoms (#1 above), those who also had 
corresponding positive physical sign for a MSD of the shoulder, elbow, or wrist, met our 
epidemiological case definition of an UE MSD[31]. The case definitions considered for this 
study were rotator cuff tendonitis, biceps tendonitis, lateral or medial epicondylitis, radial 
tunnel syndrome, cubital tunnel syndrome, deQuervain’s tenosynovitis, wrist flexor or 
extensor tendonitis, or carpal tunnel syndrome (defined in the following paragraph) [31].
Carpal tunnel syndrome (CTS)—CTS cases were contained within the UE MSD 
category, but we also evaluated CTS cases separately because the FSS (from the Boston CTS 
Questionnaire) was designed to specifically evaluate function of patients with CTS, CTS is 
one of the most expensive work-related diagnoses, and we had a small but reasonable 
number of cases to allow this study. Subjects with typical median nerve symptoms and 
abnormal median neuropathy of the same hand met our case definition for CTS [44]. Median 
nerve symptoms included numbness, tingling, burning, or pain in at least one of the thumb, 
index, or middle fingers, reported on a hand diagram [45, 46]. Criteria for abnormal median 
neuropathy was defined as median distal motor latency greater than 4.5 milliseconds (ms), 
median distal sensory latency greater than 3.5 ms, or median-ulnar sensory latency 
difference greater than 0.5 ms [47].
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Work limitations due to UE symptoms—Subjects who reported UE symptoms were 
asked to complete six additional items from the University of Michigan Upper Extremity 
Questionnaire (UEQ) [48, 49], to describe work limitations that resulted from having UE 
symptoms. We created a composite work limitations outcome from these questionnaire items 
which included self-reported limitations in work ability or productivity, or missing days 
from work, having job restrictions, or changing jobs or companies due to one’s symptoms. 
We have used a similar case definition for work limitations in our prior studies [32, 50].
Statistical Analysis
Descriptive statistics were calculated for the study population and the frequencies of each 
case definition. We ran correlations between the functional measures using Spearman rank 
correlations. We considered correlation coefficients of 0.7 to 0.9 to be strong, 0.4 to 0.7 
moderate, and less than 0.4 weak [51]. We expected moderate correlations at best between 
the measures based on differences in the constructs each measure was designed to assess, as 
well as the strength of associations that have been shown in prior studies [19, 23, 3]. 
Because lower scores on the SF-8 indicate worse health, whereas higher scores on all of the 
other measures indicate greater disability, negative correlations were expected between the 
SF-8 (PCS-8) and the other measures.
We determined if there were statistically significant differences in mean scores between 
cases and non-cases for each cases definition on each of the measures using Student’s t-tests. 
We also reported the effect sizes (Cohen’s D) to show the magnitude of the differences that 
were detected between cases and non-cases for each case definition on each functional 
measure.
Finally, we compared the sensitivity and specificity of each measure across each of the case 
definitions for UE symptoms, UE MSD, CTS, and work limitations, to evaluate how well 
each measure identified functional impairments across a range of UE case definitions. We 
selected a cut-point for each measure using normative population scores from the scientific 
literature. We selected a cut-point of 8.81 points for the 1-year recall modified DASH-W 
from the U.S. normative population mean value for the standard 1-week recall version of the 
measure [52]. We selected the U.S. population mean value of 50 as the cut-point for the SF-8 
physical component score [26]. As the FSS was designed for a clinical population, there has 
been no population mean score determined. Therefore, subjects whose score was more than 
0.5 standard deviations (SD) above the mean were considered as having functional 
limitations. Our PrediCTS cohort at 6 months had an average FSS score of 1.14 (SD 0.38)
[32]. We used a score difference of (0.5(SD) + Mean), or 1.3 points as a cut-point for the 
FSS. This value shows slightly less impairment than the post-surgical average score for CTS 
patients as previously reported by Levine and colleagues (FSS score = 1.9) [12]. Sensitivity 
and specificity could not be calculated for the QuickDASH since it was only completed by 
symptomatic workers. Analyses were conducted using R version 3.1 and SAS Version 9.3 
(Statistical Analysis System Institute, Cary, NC).
Gardner et al. Page 6














From the original PrediCTS cohort, 573 subjects were included in the present analyses. The 
majority of subjects were male (62%), with a mean age of 38.4 years (SD 10.8), and the 
largest proportion was employed in construction trades (31%) (see Table 1). Among the full 
cohort, 40% of subjects had UE symptoms and 25% of the cohort had symptoms and signs, 
meeting an UE MSD case definition. The prevalence of work limitations due to UE 
symptoms and CTS were substantially lower, 9% and 4%, respectively. Compared with a 
clinical population in which 100% of subjects would be symptomatic and would be seeking 
treatment, there was a relatively low prevalence of disease in this actively working 
population, with only 12% of the overall cohort reporting having sought treatment from a 
medical professional in the past year.
Distributions of functional outcome scores
Descriptive statistics including distributions of scores, means, and median scores for each 
measure are shown in Table 2. Subject responses represented the full range of possible 
scores on each measure; however, the relatively low median scores across all measures 
suggested a relatively moderate MSD disease spectrum in this cohort.
Correlations between measures
Correlations among the measures ranged from poor to strong (−0.34 to 0.85) (Table 3). The 
1-year recall modified QuickDASH was strongly correlated to the modified FSS (r=0.85) 
and the 1-year recall modified DASH-W (r=0.76). Correlations of the SF-8 PCS-8 with other 
measures were weak to moderate (−0.34–−0.43).
Performance of the measures against 4 UE case definitions
Results of t-tests showed statistically significant differences on all functional measures 
between cases and non-cases for UE symptoms, UE MSD, CTS, and work limitations (Table 
4). Cases reported higher levels of ADL limitations, work disability, and worse overall 
health than non-cases for each outcome. Effect sizes showed larger differences for all 
measures between cases and non-cases of CTS and work limitations. For CTS, the largest 
differences between cases and non-cases were shown with the modified FSS; for work 
limitations the largest differences between cases and non-cases were seen on the 1-year 
recall modified DASH-W.
Applying one cut-point for each measure across all case definitions allowed us to compare 
the sensitivity and specificity of each measure for the four UE case definitions (Table 5). In 
general, sensitivity of all measures was low and specificity was high in relation to UE 
symptoms and UE MSD. Sensitivity was higher for classifying workers with CTS and work 
limitations for all measures. The 1-year recall modified DASH-W showed the highest 
sensitivity in relation to the work limitations case definition.
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This study examined the utility of several measures of work ability, functional limitations, 
and overall health for a range of UE health outcomes in a working population. This study 
helps to fill important gaps in the literature as few previous studies have directly compared 
these functional measures for various musculoskeletal case definitions or in an actively 
working population. Workers with UE symptoms, UE MSD, CTS, and work limitations due 
to UE symptoms reported worse ADL function, more limited work performance, and worse 
overall health than non-cases. Measures generally showed higher sensitivity and lower 
specificity with increasing levels of impairment, suggesting that measures performed better 
with more defined states of disease in this generally healthy population.
Measures designed to assess similar constructs of health and function were moderately to 
strongly correlated with one another, such as the modified versions of the QuickDASH and 
FSS which both address functional performance of daily activities. The strong correlation 
observed between the 1-year recall modified QuickDASH and DASH-W (r=0.76) is 
consistent with the findings of Fan et al., comparing the standard QuickDASH and DASH 
Work module (r=0.63) in active workers with UE symptoms and clinical cases for UE MSD 
[19] and those of House et al. comparing the full DASH and DASH-W in workers with 
hand-arm vibration syndrome (r=0.64) [22]. In another study that compared the full Boston 
Carpal Tunnel Questionnaire (BCTQ), from which the FSS is taken, stronger correlations 
were observed between the BCTQ and the full DASH, than with measures of overall health 
such as the SF-36, from which the SF-8 was developed [25]. Our findings are consistent 
with those of Leite et al., with strong correlations observed between the modified FSS and 1-
year recall modified QuickDASH, but weaker correlations with the SF-8 physical 
component score [25].
Many previous studies have shown that clinical patients with UE MSD report problems with 
functional performance [11, 14, 53, 54]. Studies in non-clinical populations are limited, but 
the growing body of literature suggests that active workers with UE symptoms also 
experience difficulties in ADL and work performance [19–21, 55, 23]. Even in this relatively 
young, healthy working population in which few workers sought medical treatment (12%), 
cases for all outcomes reported more difficulty performing ADL and work activities. In 
addition, workers with UE conditions also perceived themselves to have lower overall 
health, as measured by the SF-8. These findings provide support for the ability of all of the 
measures to discriminate statistically significant differences between cases and non-cases 
along a range of severity for UE conditions in workers.
The sensitivity and specificity of measures can vary among patients in different settings or 
different stages of disease severity. Our findings showed higher sensitivity of measures with 
case definitions that suggest greater levels of impairment, whereas the specificity was lower. 
These findings suggest that functional measures showed weaker ability to discriminate 
between workers at lower levels of disease severity. Measures that are more closely related 
to the outcome are more likely to be sensitive to discriminating cases from non-cases [9]. 
The DASH-W is an UE region-specific measure which was developed for clinical 
populations, and has performed well in relation to a variety of UE disorders [56]. In our 
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study, the 1-year recall modified DASH-W showed the highest sensitivity in relation to our 
work limitations outcome. The FSS is a condition-specific measure designed for use with 
patients seeking treatment for CTS, and showed its highest sensitivity for CTS versus the 
other UE case definitions. Even a measure of overall physical health, the SF-8 physical 
scale, showed differences between cases/non-cases for each UE outcome in this study. 
Selection of appropriate measures should be guided by the outcome of interest and which 
measures relate best to the outcome.
As described in a review of functional measures for workers with UE MSDs, few measures 
have been developed specifically for identifying mild levels of impairment in relatively 
healthy working populations [28]. Salerno et al. recommended three measures that were 
developed for research application as the most relevant measures for mild UE conditions: the 
Nordic Musculoskeletal Questionnaire (NMQ), the Neck and Upper Limb Instrument 
(NULI), and the UEQ which included items from which our work limitations outcome was 
derived [28]. Although several measures including the DASH and FSS have been used in 
previous studies of workers, few studies have tested their performance among workers with 
mild to moderate UE conditions [28, 19–21]. Our findings provide new evidence supporting 
the use of these measures in a mildly impaired population, even though they were primarily 
designed for clinical application.
One limitation of our study was in the design of our questionnaire. The 1-year recall 
modified QuickDASH was only completed by subjects with symptoms, thus we could not 
calculate t-tests between scores for cases and non-cases or sensitivity and specificity. All 
measures used a 1-year recall period except for the SF-8 which used the standard 4-week 
recall period. This difference in recall periods may have contributed to the weak correlations 
found between the SF-8 PCS-8 and other measures. Modifying the recall periods from those 
suggested by developers of the QuickDASH, DASH-W, and FSS may limit comparisons of 
our data with previous studies or with normative data. According to a recent study by 
Norquist et al., recall periods for patient-reported outcome measures should depend upon the 
attributes of the disease or phenomenon of interest [57]. Our study was longitudinal with the 
frequency of follow-up of approximately one year. Workers reported on symptoms that 
ranged from mild to severe and were episodic in nature. The recall periods chosen for the 
measures included in our questionnaires were selected to correspond with the one-year recall 
period for the Nordic-style symptom questions. Some authors also caution that lengthening 
the recall period of measures may cause subjects to underreport functional limitations due to 
symptoms that occurred as much as 1 year prior [58, 59]. Stepan et al., however, showed that 
patients with orthopedic hand and elbow injuries were able to accurately recall their baseline 
functional status on the QuickDASH up to 2 years following an initial office visit [54].
An important strength of our study was the simultaneous comparison of multiple health 
measures across a range of UE disease severity. We assessed how well various measures 
were associated with common MSDs and functional work outcomes. Measures are often 
chosen without regard to how well they relate to the research question or outcome being 
studied. Previous studies of functional and disability measures have explored reliability and 
validity, but seldom provide guidance to researchers and clinicians as to which measure may 
be most applicable in a given setting or population. Our study population was an active 
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working population rather than a clinical population. Most of the measures in this study 
were either tested in or designed primarily for use in clinical populations and few studies 
have examined their utility in working populations with a wider range of disease severity. 
Although all of the functional and work limitation measures were able to detect differences 
between the case and non-case groups of active workers across a range of UE health 
conditions, our results suggest that measures most closely related to the outcome of interest 
may perform better. The 1-year recall modified DASH-W showed the highest sensitivity and 
largest effect size for distinguishing workers with and without work limitations, and the FSS 
showed better performance for the CTS case definition versus the other UE case definitions. 
Additional longitudinal studies in active working populations are needed. Future work will 
look at the responsiveness of the measures to detect clinically meaningful change over time 
and the ability of different measures to predict future disability among active workers. 
Assessment of functional outcomes is important in both research and clinical practice, 
however, the performance of measures in the population and setting of interest should be 
considered.
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Table 1
Demographic characteristics of the study population and frequencies of the outcomes (n=573)
Characteristic Mean (SD)
Age 38.4 (10.8)
Body mass index (kg/m2) 29.9 (7.0)
n (%)
Gender
 Male 353 (62)
 Female 220 (38)
Job Category
 Construction 180 (31)
 Service 160 (28)
 Office/Clerical 94 (17)
 Technical 54 (9)
 Unemployed 85 (15)
Sought treatment for upper extremity symptoms from a medical professional, in the past year 70 (12)
Outcomes n (%)
Upper extremity symptoms 228 (40)
 General work limitations due to upper extremity symptoms 50 (9)
Upper extremity musculoskeletal disorder 145 (25)
 Carpal tunnel syndrome 24 (4)
Abbreviations: SD, standard deviation.
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Table 2
Distributions of scores of each functional measure in the study population (n=573)
Measures Number of useable observations Mean (SD) Median (IQR) Range of subject scores
QuickDASH (1-year recall modified)a,b 226 27.3 (21.5) 21.6 (27.3) 0–95.5
Functional Status Scale (modified recall)b 573 1.3 (0.7) 1 (0.4) 1–5
DASH-W (1-year recall modified)b 553 9.1 (19.6) 0 (6.3) 0–100
SF-8 physical component score c 573 52.3 (7.4) 54.2 (7.3) 13.6–66.0
Abbreviations: IQR, interquartile range; SD, standard deviation; DASH, Disabilities of the Arm, Shoulder, and Hand; DASH-W, DASH Work 
module; SF, short form.
a
The 1-year recall modified QuickDASH was completed only by subjects who reported upper extremity symptoms.
b
Higher scores indicate greater disability.
c
Lower scores indicate worse health.
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Table 3
Spearman correlation coefficients between the functional measures (n=573)











QuickDASH (1-year recall modified) 1
 p
 combined n




 combined n 226
DASH-W (1-year recall modified) 0.76 0.63 1
 p <.0001 <.0001
 combined n 215 553
SF-8 Physical component score −0.43 −0.35 −0.34 1
 p <.0001 <.0001 <.0001
 combined n 226 573 553
Abbreviations: DASH, Disabilities of the Arm, Shoulder, and Hand; DASH-W, DASH Work module; SF, short form.
a
Higher scores indicate greater disability.
b
Lower scores indicate worse health.
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